학술논문
Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.
Document Type
Article
Author
Source
Clinical & Applied Thrombosis/Hemostasis; Jan-Dec2023, Vol. 29, p1-16, 16p
Subject
Language
ISSN
10760296
Abstract
Copyright of Clinical & Applied Thrombosis/Hemostasis is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)